|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| - INR | -.--% |
|
+697.75% | +207.36% |
| 06-22 | Bafna Pharmaceuticals Limited Announces Board and Committee Changes | CI |
| 05-29 | Bafna Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 2.59B 27.18M 23.51M 21.95M 20.14M 37.88M 38.48M 258M 101M 1.3B 102M 99.83M 4.29B | P/E 2024 |
25.2x | P/E 2025 | 42.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.83B 29.78M 25.76M 24.06M 22.07M 41.51M 42.17M 282M 111M 1.42B 112M 109M 4.7B | EV / Sales 2024 |
1.37x | EV / Sales 2025 | 1.38x |
| Free-Float |
9.78% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 1980-12-31 | |
Melagiri Sridhar
DFI | Director of Finance/CFO | - | - |
| Compliance Officer | - | 2024-05-28 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2020-09-09 | |
| Director/Board Member | - | 2020-09-09 | |
| Chairman | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +697.75% | - | - | 70.66M | |
| -0.31% | -2.80% | +21.93% | +70.77% | 49.14B | |
| +4.40% | +12.38% | +67.88% | +144.61% | 40.36B | |
| -0.89% | -0.18% | -1.54% | +21.00% | 12.53B | |
| +0.56% | -0.08% | +19.46% | +71.48% | 11.6B | |
| -0.38% | -0.57% | +33.08% | +134.53% | 9.07B | |
| +1.99% | +4.41% | +20.08% | +36.28% | 6.97B | |
| +1.82% | -3.13% | +39.21% | -11.16% | 6.94B | |
| +0.40% | +4.05% | +12.51% | +183.63% | 6.72B | |
| +6.44% | +8.69% | -26.17% | +21.48% | 5.59B | |
| Average | +1.33% | +1.65% | +20.72% | +74.74% | 16.55B | |
| Weighted average by Cap. | +1.44% | +1.62% | +31.38% | +88.35% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.52B 16.02M 13.86M 12.94M 11.87M 22.33M 22.68M 152M 59.59M 764M 60.16M 58.84M 2.53B | 1.46B 15.33M 13.26M 12.38M 11.36M 21.36M 21.7M 145M 57.01M 731M 57.55M 56.29M 2.42B |
| Net income | 73.48M 772K 668K 624K 572K 1.08M 1.09M 7.32M 2.87M 36.83M 2.9M 2.84M 122M | 41.52M 436K 377K 352K 323K 608K 618K 4.14M 1.62M 20.81M 1.64M 1.6M 68.81M |
| Net Debt | 230M 2.42M 2.09M 1.95M 1.79M 3.37M 3.42M 22.9M 8.99M 115M 9.07M 8.87M 381M | 248M 2.6M 2.25M 2.1M 1.93M 3.63M 3.68M 24.66M 9.68M 124M 9.77M 9.56M 410M |
Employees
-
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- BAFNAPH Stock
- BAFNAPH Stock
Select your edition
All financial news and data tailored to specific country editions
